Page last updated: 2024-12-05

amprotropine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Amprotropine is a synthetic muscarinic acetylcholine receptor antagonist that has been investigated for its potential therapeutic applications. It was first synthesized in the 1960s and has been shown to possess a number of pharmacological effects. Amprotropine is a selective antagonist of the M1 and M3 subtypes of muscarinic receptors, and it has been shown to exhibit anticholinergic activity, reducing the effects of acetylcholine. This property has led to its investigation as a potential treatment for conditions such as urinary incontinence, Parkinson's disease, and irritable bowel syndrome. Amprotropine's effects on the nervous system, particularly its ability to modulate cholinergic signaling, are of significant interest in understanding the underlying mechanisms of various neurological disorders. Further research is ongoing to explore its potential therapeutic applications and safety profile.'

Cross-References

ID SourceID
PubMed CID8645
CHEMBL ID4302313
CHEBI ID2685
MeSH IDM0150302

Synonyms (22)

Synonym
q1s268dprs ,
unii-q1s268dprs
benzeneacetic acid, alpha-(hydroxymethyl)-, 3-(diethylamino)-2,2-dimethylpropyl ester
amprotropine
148-32-3
AC1L1RF1 ,
[3-(diethylamino)-2,2-dimethylpropyl] 3-hydroxy-2-phenylpropanoate
AC1Q62RN ,
1-propanol, 3-(diethylamino)-2,2-dimethyl-, tropate (ester)
benzeneacetic acid, .alpha.-(hydroxymethyl)-, 3-(diethylamino)-2,2-dimethylpropyl ester
3-diethylamino-2,2-dimethylpropyl tropate
tropic acid, 3-(diethylamino)-2,2-dimethylpropyl ester
(+/-)-3-diethylamino-2,2-dimethylpropyl tropate
CHEBI:2685
ORXLOAFNULMXBG-UHFFFAOYSA-N
[3-(diethylamino)-2,2-dimethyl-propyl] 3-hydroxy-2-phenyl-propanoate
(s)-amprotropine
Q5673348
3-(diethylamino)-2,2-dimethylpropyl 3-hydroxy-2-phenylpropanoate
DTXSID90933277
Q27105766
CHEMBL4302313
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.59 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]